Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Marine Sroussi"'
Autor:
Sophie Mouillet-Richard, Angélique Gougelet, Bruno Passet, Camille Brochard, Delphine Le Corre, Caterina Luana Pitasi, Camille Joubel, Marine Sroussi, Claire Gallois, Julien Lavergne, Johan Castille, Marthe Vilotte, Nathalie Daniel-Carlier, Camilla Pilati, Aurélien de Reyniès, Fatima Djouadi, Sabine Colnot, Thierry André, Julien Taieb, Jean-Luc Vilotte, Béatrice Romagnolo, Pierre Laurent-Puig
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-17 (2024)
Abstract Background The mesenchymal subtype of colorectal cancer (CRC), associated with poor prognosis, is characterized by abundant expression of the cellular prion protein PrPC, which represents a candidate therapeutic target. How PrPC is induced i
Externí odkaz:
https://doaj.org/article/6c482fe7bb844cb5b3a5a20ec371350b
Autor:
Jean Bastin, Marine Sroussi, Ivan Nemazanyy, Pierre Laurent-Puig, Sophie Mouillet-Richard, Fatima Djouadi
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-16 (2023)
Abstract Background Colorectal cancer (CRC) can be classified into four molecular subtypes (CMS) among which CMS1 is associated with the best prognosis, while CMS4, the mesenchymal subtype, has the worst outcome. Although mitochondria are considered
Externí odkaz:
https://doaj.org/article/08da4395fe2b4e27ba67cb17740e7c9b
Autor:
Simon Garinet, Audrey Didelot, Laetitia Marisa, Guillaume Beinse, Marine Sroussi, Françoise Le Pimpec-Barthes, Elizabeth Fabre, Laure Gibault, Pierre Laurent-Puig, Sophie Mouillet-Richard, Antoine Legras, Hélène Blons
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-12 (2023)
Abstract Background In Lung adenocarcinoma (LUAD), targeted therapies and immunotherapies have moved from metastatic to early stage and stratification of the relapse risk becomes mandatory. Here we identified a miR-200 based RNA signature that deline
Externí odkaz:
https://doaj.org/article/904733005c644c07940174895ea01e79
Autor:
Carlos Lopez-Otin, Christophe Klein, Chantal Desdouets, Guido Kroemer, Pierre Laurent-Puig, Jonathan Pol, Sophie Mouillet-Richard, Gautier Stoll, Isabelle Martins, Maria Perez-Lanzon, Vincent Carbonnier, Pierre Cordier, Fatima Domenica Elisa De Palma, Adriana Petrazzuolo, Floriane Arbaretaz, Khady Mangane, Helene Fohrer Ting, Juliette Paillet, Delphine Le Corre, Wenjjin Xiao, Marine Sroussi, Maria Chiara Maiuri
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 6 (2023)
Background Progress in breast cancer (BC) research relies on the availability of suitable cell lines that can be implanted in immunocompetent laboratory mice. The best studied mouse strain, C57BL/6, is also the only one for which multiple genetic var
Externí odkaz:
https://doaj.org/article/57aae1981bde44aba4b44c6f135bd53d
Autor:
Sophie Mouillet-Richard, Séverine Martin-Lannerée, Delphine Le Corre, Théo Z. Hirsch, Alexandre Ghazi, Marine Sroussi, Camilla Pilati, Aurélien de Reyniès, Fatima Djouadi, Nicolas Vodovar, Jean-Marie Launay, Pierre Laurent-Puig
Publikováno v:
Oncogene. 41:4397-4404
The cellular prion protein PrPC partners with caveolin-1 (CAV1) in neurodegenerative diseases but whether this interplay occurs in cancer has never been investigated. By leveraging patient and cell line datasets, we uncover a molecular link between P
Autor:
Marine Sroussi, Edith Rosado
Publikováno v:
médecine/sciences. 38:348-350
Publikováno v:
médecine/sciences. 37:970-972
Autor:
Marine, Sroussi, Edith, Rosado
Publikováno v:
Medecine sciences : M/S. 38(4)
Autor:
Sophie, Mouillet-Richard, Séverine, Martin-Lannerée, Delphine, Le Corre, Théo Z, Hirsch, Alexandre, Ghazi, Marine, Sroussi, Camilla, Pilati, Aurélien, de Reyniès, Fatima, Djouadi, Nicolas, Vodovar, Jean-Marie, Launay, Pierre, Laurent-Puig
Publikováno v:
Oncogene. 41(38)
The cellular prion protein PrP
Autor:
Florian Estrade, Magalie P. Tardy, Damien Pouessel, Morgan Rouprêt, Benoit Rousseau, Hélène Gauthier, Pernelle Lavaud, Marianne Lorcet, Yann Neuzillet, Thierry Lebret, Nadine Houede, Yohann Loriot, Yves Allory, Stéphane Culine, Brigitte Laguerre, Camelia Radulescu, Gwenaelle Gravis, Delphine Borchiellini, Stéphane Oudard, Marine Gross-Goupil, Marine Sroussi, Aude Flechon, Sophie Tartas, Rémi Delva, Olivier Huillard, Nicolas Penel, Elodie Mussat, Aurélien Gobert, Phillipe Barthélémy, Reza Elaidi, Mathilde Guerin
Publikováno v:
Clinical Genitourinary Cancer
Clinical Genitourinary Cancer, Elsevier, 2019, ⟨10.1016/j.clgc.2019.11.014⟩
Clinical Genitourinary Cancer, 2019, ⟨10.1016/j.clgc.2019.11.014⟩
Clinical Genitourinary Cancer, Elsevier, 2019, ⟨10.1016/j.clgc.2019.11.014⟩
Clinical Genitourinary Cancer, 2019, ⟨10.1016/j.clgc.2019.11.014⟩
International audience; BACKGROUND:Neuroendocrine carcinoma of the urinary bladder (NCUB) is rare, accounting for < 1% of bladder cancer cases, with scarce reported data available.MATERIALS AND METHODS:We retrospectively reviewed the data from patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6607d9ac43aa8830d47353843551a856
https://hal.umontpellier.fr/hal-02556645
https://hal.umontpellier.fr/hal-02556645